Posted by Michael Wonder on 14 Mar 2020
Insulin costs may be capped in a Medicare program
11 March 2020 - If drug companies and insurers agree to participate, the Trump administration proposes limiting insulin costs to $35 a month for some older Americans.
A new Medicare pilot program would lower the cost of insulin to $35 a prescription for older Americans who need the lifesaving drugs, the Trump administration announced Wednesday.
If insulin manufacturers and insurers agree to offer the plans — which are voluntary — then people 65 and older who need insulin could save an average of $446 a year beginning in January 2021, according to Medicare officials.
